• This record comes from PubMed

Co-transplantation of olfactory ensheathing glia and mesenchymal stromal cells does not have synergistic effects after spinal cord injury in the rat

. 2010 Apr ; 12 (2) : 212-25.

Language English Country England, Great Britain Media print

Document type Journal Article, Research Support, Non-U.S. Gov't

Links

PubMed 20196694
DOI 10.3109/14653240903440103
PII: S1465-3249(10)70383-2
Knihovny.cz E-resources

BACKGROUND AIMS: Olfactory ensheathing glia (OEG) and mesenchymal stromal cells (MSC) are suitable candidates for transplantation therapy of spinal cord injury (SCI). Both facilitate functional improvement after SCI by producing trophic factors and cytokines. In this study, the co-transplantation of both types of cells was studied to clarify their additive and/ or synergistic effects on SCI. METHODS: A balloon-induced compression lesion was used to produce SCI in rats. OEG, MSC or both OEG and MSC (3 x 10(5) cells of each cell type) were implanted by intraspinal injection 1 week after SCI. The effect of transplantation was assessed using behavioral, electrophysiologic and histologic methods. RESULTS: Hindlimb function was examined with Basso, Beattie and Bresnahan (BBB) and Plantar tests. Improvement was found in all three groups of transplanted rats with different time-courses, but there was no significant difference among the groups at the end of the experiment. Motor-evoked potentials after SCI decreased in amplitude from 7 mV to 10 microV. Linear regression analysis showed a modest recovery in amplitude following transplantation, but no change in the control rats. Histologic findings showed that the white and gray matter were significantly spared by transplantation after SCI. CONCLUSIONS: Functional improvement was achieved with transplantation of OEG and/or MSC, but the co-transplantation of OEG and MSC did not show synergistic effects. The poor migration of OEG and MSC might prevent their concerted action. Pre-treatment with a Rho antagonist and a combination of intraspinal and intravenous injection of the cells might be beneficial for SCI therapy.

References provided by Crossref.org

Newest 20 citations...

See more in
Medvik | PubMed

The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury

. 2019 Sep 12 ; 20 (18) : . [epub] 20190912

The Effect of iPS-Derived Neural Progenitors Seeded on Laminin-Coated pHEMA-MOETACl Hydrogel with Dual Porosity in a Rat Model of Chronic Spinal Cord Injury

. 2019 Apr ; 28 (4) : 400-412. [epub] 20190118

The Effect of Human Mesenchymal Stem Cells Derived from Wharton's Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application

. 2018 May 17 ; 19 (5) : . [epub] 20180517

Comparison of intraspinal and intrathecal implantation of induced pluripotent stem cell-derived neural precursors for the treatment of spinal cord injury in rats

. 2015 Dec 22 ; 6 () : 257. [epub] 20151222

Human mesenchymal stem cells modulate inflammatory cytokines after spinal cord injury in rat

. 2014 Jun 25 ; 15 (7) : 11275-93. [epub] 20140625

Transplantation of predifferentiated adipose-derived stromal cells for the treatment of spinal cord injury

. 2011 Oct ; 31 (7) : 1113-22. [epub] 20110601

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...